ZYME – zymeworks inc. (US:NASDAQ)
Stock Stats
News
Zymeworks Inc. (NYSE: ZYME) had its price target raised by analysts at Wells Fargo & Company from $12.00 to $14.00. They now have an "equal weight" rating on the stock.
Zymeworks Inc. (NYSE: ZYME) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $18.00 price target on the stock.
Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases [Yahoo! Finance]
Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory Diseases
Zymeworks Inc. (NYSE: ZYME) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Form 4 Zymeworks Inc. For: Dec 10 Filed by: Miller Derek John Michael
Form 4 Zymeworks Inc. For: Dec 10 Filed by: Campoy Carlos
Form 4 Zymeworks Inc. For: Dec 10 Filed by: Cesano Alessandra
Form 4 Zymeworks Inc. For: Dec 10 Filed by: Neu Kelvin
Form 4 Zymeworks Inc. For: Dec 10 Filed by: Davidson Nancy
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.